12885_2018_4091_MOESM2_ESM.docx (13.53 kB)
Additional files 2: of RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis
journal contribution
posted on 2018-02-17, 05:00 authored by Lin Yang, Anna Alyasova, Dingwei Ye, Antonia Ridolfi, Luca Dezzani, Robert MotzerTable S2 Tumor responses (RECIST v1.0) of Asian and non-Asian patients in the overall population and in the first-line therapy cohorts. (DOCX 13 kb)
